Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...
COVID-19 Vaccine
Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.
News4Jax4d
Unexpected aftermath: Study finds COVID infection increases risk of heart attack, stroke
When COVID-19 swept across the globe, isolation, social distancing and wearing masks became the norm. Since then, more than ...
Yahoo Finance4d
Moderna’s Shot Sales, Canceled Contract Lead to Another Loss
Moderna invested heavily in manufacturing during the pandemic to meet high demand for its Covid vaccine. The company has been reducing capacity as demand for the shot falls. Last month ...
Reuters5d
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna's total revenue for the fourth quarter fell nearly 66% to $966 million, but beat analysts' expectations of $942.84 million. Most of those sales were generated by the COVID shot ...
Dallas Morning News24d
CIA now says COVID-19 ‘more likely’ to have come from lab than nature
A local resident receives the Moderna COVID-19 vaccine shot at a center, June 30, 2021, in the Sumida ward of Tokyo. (Eugene Hoshiko / AP) NEW YORK - The Central Intelligence Agency has assessed ...